Literature DB >> 21483013

Pathogenesis of non-Hodgkin's lymphoma.

Hendrik Nogai1, Bernd Dörken, Georg Lenz.   

Abstract

The understanding of the molecular pathogenesis of non-Hodgkin's lymphomas (NHL) has significantly improved in recent years. Advances in molecular biology and genetics lead to the identification and characterization of several oncogenic pathways involved in lymphomagenesis. This knowledge will ultimately lead to improved diagnostic and therapeutic strategies for patients with NHL. This review summarizes current concepts of the molecular pathogenesis of the most common NHL subtypes, with a special emphasis on diffuse large B-cell lymphoma, the most common lymphoma subtype.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21483013     DOI： 10.1200/JCO.2010.33.3252

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


  83 in total

Review 1.  Biology of double-hit B-cell lymphomas.

Authors:  R Coleman Lindsley; Ann S LaCasce
Journal:  Curr Opin Hematol       Date:  2012-07       Impact factor: 3.284

2.  Prognostic significance of T cell subsets in peripheral blood of B cell non-Hodgkin's lymphoma patients.

Authors:  Mehdi Dehghani; Shokouh Sharifpour; Zahra Amirghofran; Hamid Reza Zare
Journal:  Med Oncol       Date:  2012-02-04       Impact factor: 3.064

3.  MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma.

Authors:  Hanne Due; Anna Amanda Schönherz; Laura Ryø; Maria Nascimento Primo; Ditte Starberg Jespersen; Emil Aagaard Thomsen; Anne Stidholt Roug; Min Xiao; Xiaohong Tan; Yuyang Pang; Ken H Young; Martin Bøgsted; Jacob Giehm Mikkelsen; Karen Dybkær
Journal:  Blood Adv       Date:  2019-04-09

4.  Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.

Authors:  Christian Grommes; Alessandro Pastore; Nicolaos Palaskas; Sarah S Tang; Carl Campos; Derrek Schartz; Paolo Codega; Donna Nichol; Owen Clark; Wan-Ying Hsieh; Dan Rohle; Marc Rosenblum; Agnes Viale; Viviane S Tabar; Cameron W Brennan; Igor T Gavrilovic; Thomas J Kaley; Craig P Nolan; Antonio Omuro; Elena Pentsova; Alissa A Thomas; Elina Tsyvkin; Ariela Noy; M Lia Palomba; Paul Hamlin; Craig S Sauter; Craig H Moskowitz; Julia Wolfe; Ahmet Dogan; Minhee Won; Jon Glass; Scott Peak; Enrico C Lallana; Vaios Hatzoglou; Anne S Reiner; Philip H Gutin; Jason T Huse; Katherine S Panageas; Thomas G Graeber; Nikolaus Schultz; Lisa M DeAngelis; Ingo K Mellinghoff
Journal:  Cancer Discov       Date:  2017-06-15       Impact factor: 39.397

5.  A new strategy for label-free detection of lymphoma cancer cells.

Authors:  Nicola M Martucci; Ilaria Rea; Immacolata Ruggiero; Monica Terracciano; Luca De Stefano; Nunzia Migliaccio; Camillo Palmieri; Giuseppe Scala; Paolo Arcari; Ivo Rendina; Annalisa Lamberti
Journal:  Biomed Opt Express       Date:  2015-03-19       Impact factor: 3.732

6.  Presence of multiple abnormal immunologic markers is an independent prognostic factor of diffuse large B-cell lymphoma.

Authors:  Yiwen Cao; Zhenhua Liu; Wen Wu; Ying Qian; Qin Shi; Rong Shen; Binshen Ouyang; Pengpeng Xu; Shu Cheng; Jin Ye; Yiming Lu; Chaofu Wang; Chengde Yang; Li Wang; Weili Zhao
Journal:  Front Med       Date:  2019-01-31       Impact factor: 4.592

7.  Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.

Authors:  Jihyun Chung; Vrajesh Karkhanis; Robert A Baiocchi; Saïd Sif
Journal:  J Biol Chem       Date:  2019-03-18       Impact factor: 5.157

8.  Rituximab for non-Hodgkin's lymphoma: a story of rapid success in translation.

Authors:  Andrew M Harrison; Nassir M Thalji; Alexandra J Greenberg; Carmen J Tapia; Anthony J Windebank
Journal:  Clin Transl Sci       Date:  2013-10-03       Impact factor: 4.689

9.  Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions.

Authors:  Therese Högfeldt; Crystal Jaing; Kevin Mc Loughlin; James Thissen; Shea Gardner; Abeer A Bahnassy; Baback Gharizadeh; Joachim Lundahl; Anders Österborg; Anna Porwit; Abdel-Rahman N Zekri; Hussein M Khaled; Håkan Mellstedt; Ali Moshfegh
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

10.  Risk of lymphoproliferative malignancy in celiac patients with a family history of lymphoproliferative malignancy.

Authors:  Jonas F Ludvigsson; Benjamin Lebwohl; Alberto Rubio-Tapia; Joseph A Murray; Peter H R Green; Anders Ekbom
Journal:  J Gastroenterol       Date:  2013-02-27       Impact factor: 7.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.